drugset
drugset / Trial / NCT01515865

Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

NCT01515865 ↗

Phase 4 Completed 98 enrolled Shire
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To study the effect of midodrine against the symptoms of orthostatic hypotension

Timeline

Start
2012-05-23
Primary completion
2013-11-11
Completion
2013-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Midodrine Small molecule — —

Indications

orthostatic hypotension